POST Online Media Lite Edition



 

ARIAD Pharmaceuticals elects Alexander Denner as chairman

Staff writer |
Cambridge, Mass., USA - January 12, 2016, Cambridge, Mass., USA - ARIAD Pharmaceuticals, Inc., an oncology company, announced the election of Alexander J. Denner as chairman of its board of directors.

Article continues below






Dr. Denner joined the ARIAD Board of Directors in February 2014 and most recently led the Board’s search committee to select the Company’s new CEO Paris Panayiotopoulos.

Dr. Denner is the Chief Investment Officer and founding partner of Sarissa Capital Management which focuses on improving the strategies of companies to better provide shareholder value. Dr. Denner also serves as a director of Biogen Inc.

LATEST 5 MOVES FROM Massachusetts 


What to read next

ARIAD Pharma appoints Jennifer L. Herron as EVP
ARIAD Pharmaceuticals: Timothy P. Clackson president of R&D
uniQure names Maria E. Cantor as SVP, investor relations